Molecular Weight: 244.298
Molecular Formula: C13H16N4O
Canonical SMILES: O=C(C1=C2C(NC([C@]3(C)NCCC3)=N2)=CC=C1)N
InChI: 1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1
InChIKey: JNAHVYVRKWKWKQ-CYBMUJFWSA-N
Purity: 0.99
Application: For research used only
Synonyms: (R)-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole-4-carboxamide; ABT888; ABT-888; ABT 888; Veliparib
DescriptionVeliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.9 nM, respectively. In HCT-116 and HT-29 cell lines, the ability of ABT-888 to synergize the effect of the anti-cancer agents, SN38 or oxaliplatin, was determined using the SRB assay. PARP activity was significantly reduced in samples treated with SN38 in combination with ABT-888 (>4 fold at 24 h).
More details are to be found on
supplier website
